TLR9 agonist may improve melanoma Tx response.

Bibliographic Details
Published in:Dermatology Times Vol. 39; no. 10; pp. 59 - 60
Main Author: LEVITAN, DAVE
Format: Journal Article
Published: MJH Life Sciences Oct2018
Online Access:View this record in EBSCOhost